BNP Paribas Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $198M | Buy |
|
|||||
|
2025
Q1 | $190M | Buy |
|
|||||
|
2024
Q4 | $157M | Sell |
|
|||||
|
2024
Q3 | $184M | Sell |
|
|||||
|
2024
Q2 | $191M | Sell |
|
|||||
|
2024
Q1 | $204M | Sell |
|
|||||
|
2023
Q4 | $245M | Sell |
|
|||||
|
2023
Q3 | $240M | Buy |
|
|||||
|
2023
Q2 | $224M | Sell |
|
|||||
|
2023
Q1 | $242M | Buy |
|
|||||
|
2022
Q4 | $194M | Buy |
|
|||||
|
2022
Q3 | $116M | Sell |
|
|||||
|
2022
Q2 | $146M | Buy |
|
|||||
|
2022
Q1 | $132M | Buy |
|
|||||
|
2021
Q4 | $54.1M | Buy |
|
|||||
|
2021
Q3 | $37M | Sell |
|
|||||
|
2021
Q2 | $59.7M | Sell |
|
|||||
|
2021
Q1 | $73.2M | Sell |
|
|||||
|
2020
Q4 | $95M | Sell |
|
|||||
|
2020
Q3 | $128M | Buy |
|
|||||
|
2020
Q2 | $123M | Buy |
|
|||||
|
2020
Q1 | $91.2M | Sell |
|
|||||
|
2019
Q4 | $100M | Sell |
|
|||||
|
2019
Q3 | $88.1M | Buy |
|
|||||
|
2019
Q2 | $85.3M | Buy |
|
|||||
|
2019
Q1 | $68.7M | Buy |
|
|||||
|
2018
Q4 | $57.1M | Sell |
|
|||||
|
2018
Q3 | $76.9M | Buy |
|
|||||
|
2018
Q2 | $59.9M | Buy |
|
|||||
|
2018
Q1 | $47.9M | Buy |
|
|||||
|
2017
Q4 | $39.9M | Buy |
|
|||||
|
2017
Q3 | $29.3M | Buy |
|
|||||
|
2017
Q2 | $23M | Sell |
|
|||||
|
2017
Q1 | $23.8M | Buy |
|
|||||
|
2016
Q4 | $901K | Sell |
|
|||||
|
2016
Q3 | $8.52M | Sell |
|
|||||
|
2016
Q2 | $18.5M | Sell |
|
|||||
|
2016
Q1 | $17.6M | Sell |
|
|||||
|
2015
Q4 | $48.7M | Sell |
|
|||||
|
2015
Q3 | $42.2M | Buy |
|
|||||
|
2015
Q2 | $47.7M | Buy |
|
|||||
|
2015
Q1 | $41.9M | Buy |
|
|||||
|
2014
Q4 | $10.3M | Buy |
|
|||||
|
2014
Q3 | $7.37M | Sell |
|
|||||
|
2014
Q2 | $6.54M | Sell |
|
|||||
|
2014
Q1 | $7.11M | Sell |
|
|||||
|
2013
Q4 | $7.72M | Buy |
|
|||||
|
2013
Q3 | $4.85M | Buy |
|
|||||
|
2013
Q2 | $2.39M | Buy |
|